Article
Author(s):
Take all concerns seriously, listen attentively, and get back to the basics, ophthalmologist advises
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
FDA clears Grifols' Investigational New Drug application for immunoglobulin drops for the treatment of DED
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Q&A: Matthew Starr, MD, shares insights into RHONE-X trial
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Bausch + Lomb launches LUMIFY Preservative Free redness reliever eye drops in the US
Q&A: Kapil Mishra on radiation retinopathy in uveal melanoma